Multiple Sclerosis – Cladribine tablets (Mavenclad)

23rd January 2018 by Louise Hudman

Multiple Sclerosis – Cladribine tablets (Mavenclad)

This is a new guideline from NICE on a new treatment for MS. Obviously we won’t be prescribing this, but I thought it worth mentioning as we may see patients starting to use it.

It is an oral medication, given as short courses (eg for 2 years, it is given for just a few days in each of a couple of months). This compares to other medications, which are either daily and continuous, or injections, or IV medications given in hospital.

It will be used as a second line treatment in relapsing-remitting MS, or in rapidly evolving severe relapsing-remitting MS.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I’m loving LocumDeck, it’s a great piece of software."

Dr David Williams

Dr David Williams

See the full list of features within our NASGP membership plans

Membership